DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Butler PC, Elashoff M, Elashoff R et al.
A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?.
Diabetes Care 2013;
36 (07) 2118-2125
DOI: 10.2337/dc12-2713.
http://www.ncbi.nlm.nih.gov/pubmed/23645885
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.